Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

May S Freag, Ph.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Freag MS, Namgung B, Reyna Fernandez ME, Gherardi E, Sengupta S, Jang HL. Human Nonalcoholic Steatohepatitis on a Chip. Hepatol Commun. 2021 02; 5(2):217-233. PMID: 33553970.
    Citations: 9     Fields:    Translation:HumansCells
  2. Abdelaziz HM, Elzoghby AO, Helmy MW, Abdelfattah EA, Fang JY, Samaha MW, Freag MS. Inhalable Lactoferrin/Chondroitin-Functionalized Monoolein Nanocomposites for Localized Lung Cancer Targeting. ACS Biomater Sci Eng. 2020 02 10; 6(2):1030-1042. PMID: 33464839.
    Citations: 3     Fields:    Translation:Animals
  3. Freag MS, Torky AS, Nasra MM, Abdelmonsif DA, Abdallah OY. Liquid crystalline nanoreservoir releasing a highly skin-penetrating berberine oleate complex for psoriasis management. Nanomedicine (Lond). 2019 04; 14(8):931-954. PMID: 30925102.
    Citations: 2     Fields:    Translation:HumansAnimals
  4. Zayed DG, AbdElhamid AS, Freag MS, Elzoghby AO. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging. Nanomedicine (Lond). 2019 02; 14(3):225-228. PMID: 30652951.
    Citations: 4     Fields:    Translation:HumansAnimals
  5. Abdelaziz HM, Elzoghby AO, Helmy MW, Samaha MW, Fang JY, Freag MS. Liquid crystalline assembly for potential combinatorial chemo-herbal drug delivery to lung cancer cells. Int J Nanomedicine. 2019; 14:499-517. PMID: 30666110.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  6. Elzoghby AO, Freag MS. Toward improving drug delivery research in Egypt: Cancer Nanotechnology Research Laboratory (CNRL) as a role model. Drug Discov Today. 2019 02; 24(2):361-363. PMID: 30439448.
    Citations:    Fields:    Translation:Animals
  7. Gaber M, Mabrouk MT, Freag MS, Khiste SK, Fang JY, Elkhodairy KA, Elzoghby AO. Protein-polysaccharide nanohybrids: Hybridization techniques and drug delivery applications. Eur J Pharm Biopharm. 2018 Dec; 133:42-62. PMID: 30300719.
    Citations: 6     Fields:    Translation:HumansAnimals
  8. Torky AS, Freag MS, Nasra MMA, Abdallah OY. Novel skin penetrating berberine oleate complex capitalizing on hydrophobic ion pairing approach. Int J Pharm. 2018 Oct 05; 549(1-2):76-86. PMID: 30053489.
    Citations: 6     Fields:    Translation:AnimalsCells
  9. Freag MS, Saleh WM, Abdallah OY. Exploiting polymer blending approach for fabrication of buccal chitosan-based composite sponges with augmented mucoadhesive characteristics. Eur J Pharm Sci. 2018 Jul 30; 120:10-19. PMID: 29715500.
    Citations: 3     Fields:    
  10. Freag MS, Saleh WM, Abdallah OY. Laminated chitosan-based composite sponges for transmucosal delivery of novel protamine-decorated tripterine phytosomes: Ex-vivo mucopenetration and in-vivo pharmacokinetic assessments. Carbohydr Polym. 2018 May 15; 188:108-120. PMID: 29525146.
    Citations: 7     Fields:    Translation:Animals
  11. Freag MS, Elzoghby AO. Protein-inorganic Nanohybrids: A Potential Symbiosis in Tissue Engineering. Curr Drug Targets. 2018; 19(16):1897-1904. PMID: 29076428.
    Citations: 1     Fields:    Translation:HumansAnimals
  12. Abdelaziz HM, Gaber M, Abd-Elwakil MM, Mabrouk MT, Elgohary MM, Kamel NM, Kabary DM, Freag MS, Samaha MW, Mortada SM, Elkhodairy KA, Fang JY, Elzoghby AO. Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates. J Control Release. 2018 01 10; 269:374-392. PMID: 29180168.
    Citations: 54     Fields:    Translation:HumansAnimals
  13. Freag MS, Saleh WM, Abdallah OY. Self-assembled phospholipid-based phytosomal nanocarriers as promising platforms for improving oral bioavailability of the anticancer celastrol. Int J Pharm. 2018 Jan 15; 535(1-2):18-26. PMID: 29102699.
    Citations: 17     Fields:    Translation:AnimalsCells
  14. Elzoghby A, Freag M, Mamdouh H, Elkhodairy K. Zein-based Nanocarriers as Potential Natural Alternatives for Drug and Gene Delivery: Focus on Cancer Therapy. Curr Pharm Des. 2017; 23(35):5261-5271. PMID: 28641543.
    Citations: 7     Fields:    Translation:HumansAnimals
  15. Freag MS. Hyaluronate-Lipid Nanohybrids: Fruitful Harmony in Cancer Targeting. Curr Pharm Des. 2017; 23(35):5283-5291. PMID: 28552066.
    Citations: 2     Fields:    Translation:HumansAnimals
  16. Sabra S, Abdelmoneem M, Abdelwakil M, Mabrouk MT, Anwar D, Mohamed R, Khattab S, Bekhit A, Elkhodairy K, Freag M, Elzoghby A. Self-Assembled Nanocarriers Based on Amphiphilic Natural Polymers for Anti- Cancer Drug Delivery Applications. Curr Pharm Des. 2017; 23(35):5213-5229. PMID: 28552068.
    Citations: 6     Fields:    Translation:HumansAnimals
  17. Freag MS, Elnaggar YS, Abdelmonsif DA, Abdallah OY. Layer-by-layer-coated lyotropic liquid crystalline nanoparticles for active tumor targeting of rapamycin. Nanomedicine (Lond). 2016 Nov; 11(22):2975-2996. PMID: 27785978.
    Citations: 12     Fields:    Translation:HumansCells
  18. Elzoghby AO, Hemasa AL, Freag MS. Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging. J Control Release. 2016 12 10; 243:303-322. PMID: 27794493.
    Citations: 22     Fields:    Translation:HumansAnimals
  19. Freag MS, Elnaggar YS, Abdelmonsif DA, Abdallah OY. Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies. Int J Nanomedicine. 2016; 11:4799-4818. PMID: 27703348.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  20. Freag MS, Elnaggar YS, Abdallah OY. Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeation. Int J Nanomedicine. 2013; 8:2385-97. PMID: 23861584.
    Citations: 19     Fields:    Translation:Animals
  21. Freag MS, Elnaggar YS, Abdallah OY. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation. Int J Pharm. 2013 Sep 15; 454(1):462-71. PMID: 23830765.
    Citations: 13     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Freag's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (122)
Co-Authors (4)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.